Sample Tech Deals

Status:Pre-A Series
 
 
Privately Held Digital
Health Company

This is a privately held digital health company. The Company’s technology and services measure and analyze typing cadence (TC), for early detection and continuous monitoring of Central Nervous System (CNS) diseases and injuries. This company is the first provider of quantitative, sub-clinical measures of neurocognitive function with extreme granularity and stunning statistical power. 

Regenerative Bone
Medicine Company

This company was launched to develop and commercialize a class of drugs based on targeting mesenchymal stem cells (MSCs) to various sites of clinical relevance. The company's new findings have currently been demonstrated in a number of animal models for osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis. The potential opportunity for this company is to develop these drugs addressing a need for effective stem cell treatments in osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis.

Virtual Reality Company
Status: Pre-A Series
 

This company develops a line of patent pending award winning solutions for a full-on immersive virtual reality experience. These solutions include input and feedback hardware and software components to interact with virtual environments and address the issue of simulator sickness in first person applications. 

Contact Us

 

info@crossvinecapital.com

 

Tel: +1 408-785-0918 (Voice)

 

Wechat: InvestSV

Business Presence

 

USA - Palo Alto, CA

 

China:

Shanghai, Beijing

北京海淀区成府路文津国际酒店B1层  

(Wenjin International Hotel, Floor B1, Beijing)

  • Facebook Clean
  • LinkedIn Clean

© 2019 CrossVineCapital.com

 

All rights reserved